We are Epilepsy Society. The UK’s only charity transforming the lives of people with epilepsy through world-leading research, advocacy and care.

Leading care provider
Our range of care is tailored to the needs of each individual, and our professional staff are committed to maximising the life potential of everyone within our care homes.

Cutting edge research
Epilepsy Society's Chalfont Centre is unique in bringing together intellectual capital to form a powerhouse multidisciplinary team who contribute to a wide ranging spectrum of research.

Epilepsy Support
Our confidential epilepsy helpline and online information give help and support to people who are affected by epilepsy.

Advocacy
We are a voice for people with epilepsy, striving to push epilepsy up the political agenda and bring about change at government level.
Medical services
The Chalfont Centre and our Gowers unit lead the way in the most advanced techniques for the diagnosis and treatment of epilepsy.
Care services
We are the leading charity care provider, where people love to work and live. Our wide range of care is tailored to the needs of each individual, and our professional staff are committed to maximising the life potential of everyone within our care homes.
Campaigns
Our campaigns team lobby government and decision-makers on the issues that matter to people with epilepsy. From safer medicines for pregnant women to the dangers of online harm, and from medicines supply to public transport access, we raise awareness of the daily challenges facing people with epilepsy.
Latest news
Write to your MP: cost of living
It is important that people with epilepsy do not face a financial burden because of this often misunderstood condition. Use our template letter to write to your MP or councillor about the cost of living crisis.
Van Gogh: hidden art, hidden disability
Over a century after his death, iconic artist Vincent Van Gogh reminds us that epilepsy is often a hidden condition.
New safety review into topiramate (Topamax)
A new safety review is being launched into the epilepsy medication topiramate. The drug (brand name Topamax) is already known to be associated with an increased risk of congenital malformations and effects on fetal growth when taken during pregnancy.
Covid-19 booster and flu jab - autumn 2022
The Government has updated advice around the Covid-19 booster and the flu jab programmes for the autumn. This means that everyone with epilepsy, aged five and over, will be eligible for the Covid-19 booster, although they will not be automatically eligible for the flu jab.
Hot tips for coping in the heatwave
A survey* carried out by the Epilepsy Society showed that 62 per cent of people with uncontrolled seizures experience an increase in their seizure activity during unusually hot weather. In the current heatwave, it is important to make sure that you take sensible precautions to ensure that you stay cool, particularly if you know your epilepsy is sensitive to the heat.
Zach's Law to be introduced in House of Lords
Amid ongoing turmoil in Westminster, one policy unites MPs from across the political divide: Zach's Law.
Our research
Research
The ultimate goals of our current research are to spearhead personalised treatment and to incorporate genomic diagnosis into the NHS for people with epilepsy.
Therapeutic Drug Monitoring (TDM)
Therapeutic drug monitoring (TDM) is an area of clinical chemistry that specialises in measuring medication levels (concentrations) in patients, usually through blood samples but also through saliva samples.
Genomics
Read how we are working to understand the genetic architecture of each individual person's epilepsy through our world leading genomics research programme.
You can call our helpline on 01494 601 400.
Our Helpline is open five days a week, Monday to Friday 9am to 4pm, (Wednesday 9am to 7.30pm).
You can also reach us by email
helpline@epilepsysociety.org.uk.